PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.

Dalla-Volta, S; Palla, A; Santolicandro, A; Giuntini, C; Pengo, V; Visioli, O; Zonzin, P; Zanuttini, D; Barbaresi, F; Agnelli, G

Dalla-Volta, S; Palla, A; Santolicandro, A; Giuntini, C; Pengo, V; Visioli, O; Zonzin, P; Zanuttini, D; Barbaresi, F; Agnelli, G.

Affiliation

Dalla-Volta S; Istituto di Cardiologia, Università di Padova, Italy.

J Am Coll Cardiol ; 20(3): 520-6, 1992 Sep.

Article in En | MEDLINE | ID: mdl-1512328

Subject(s)

Heparin/therapeutic use; Pulmonary Embolism/drug therapy; Tissue Plasminogen Activator/therapeutic use; Acute Disease; Adult; Aged; Drug Therapy, Combination; Female; Hematologic Tests; Hemorrhage/chemically induced; Heparin/adverse effects; Humans; Lung/diagnostic imaging; Male; Middle Aged; Pulmonary Artery/diagnostic imaging; Pulmonary Embolism/diagnostic imaging; Pulmonary Embolism/physiopathology; Radiography; Radionuclide Imaging; Tissue Plasminogen Activator/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Embolism / Heparin / Tissue Plasminogen Activator Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 1992 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links